Skip to content

Sana Biotechnology SANA Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$241.99M-16.0%-$244.17M+8.5%-$234.41M+23.3%-$252.18M-2.6%-$208.67M+32.6%
$24.1M-32.3%$25.46M-32.4%$25.56M-34.7%$30.86M-17.5%$35.61M-0.7%
-$132.55M+35.7%-$143.83M+35.5%-$158.35M+30.5%-$180.74M+24.6%-$206.18M+14.1%
$17.72M-47.4%
-$7.4M-$40.24M$23.35M
$127.62M+790%$128.73M-35.6%$111.73M-44.4%$4.27M-97.9%$14.33M-93.4%
-$133.64M+40.3%-$144.77M+43.6%-$158.85M+42.2%-$185.29M+35.0%-$223.9M+18.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Sana Biotechnology generate?
Sana Biotechnology (SANA) generated -$132.6M in operating cash flow over the trailing twelve months.
What is Sana Biotechnology's free cash flow?
After $1.3M of capital expenditures, Sana Biotechnology's free cash flow was -$133.6M over the trailing twelve months, up 40.3% year over year.
Where does Sana Biotechnology's cash flow data come from?
Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.